{"name":"Momenta Pharmaceuticals, Inc.","slug":"momenta-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"US-Sourced Orencia®","genericName":"US-Sourced Orencia®","slug":"us-sourced-orencia","indication":"Other","status":"phase_1"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"M923","genericName":"M923","slug":"m923","indication":"Autoimmune and inflammatory diseases (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"US-Sourced Orencia®","genericName":"US-Sourced Orencia®","slug":"us-sourced-orencia","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"M923","genericName":"M923","slug":"m923","phase":"phase_3","mechanism":"M923 is a monoclonal antibody that targets and modulates IgG glycosylation to enhance immune function.","indications":["Autoimmune and inflammatory diseases (Phase 3 development)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQUmt4T1BmOEhubUFzeHZIZEZkLWRhbmVEWl9sTkRKTzFmUzNMZmZtT1ptNkxHYjFLRE5FQXZKejAwNWIxQTRaNUpPb0oxNUtHUlkwUTAxZ1ItSVZBUW01M3N2SWt1ZTAwSUxJS2VEYlRaekE2VTlHZlZJazFoNDhPMmhYYTdvV0pyOVFsdVBMMjhZV3VMZGNuWTRvZzBNRGlGYnJjcW9TTWpkS005eFUyby13UUdMelpSTXlla0NBc3JIN2Z5WWM5ajNxOHFEOUJwUUF0dDBmYjJ0alFBSzJTMk1rV0Y5ek1xTlE?oc=5","date":"2025-11-19","type":"pipeline","source":"Elicio Therapeutics","summary":"Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer - Elicio Therapeutics","headline":"Elicio Therapeutics Appoints Veteran CMC and Technical Operations Executive Marc J. Wolfgang as Chief Technology Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNVEFUVTJ1QXhvdmwzQXhhMUNPR0NQVzFTVFctUm5rejN4TlZPZUVlVDFYYlB1TkVteVVjcmJ0OWc4XzRscGtjdWtQcnpXM1VEbklhNmNqRHZQY01xZjlsLVk3My1RdDdLWHJ2R1ZyS3RHaU5TZFNHTl82SnIyT0lRZktfUkQ0aTBTVkRXME9FanVsZ21lVEZaS01TS3NNXzBUSTkxUWx6bUFCSVlXbGtRbWRB?oc=5","date":"2025-04-30","type":"regulatory","source":"Fierce Pharma","summary":"J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy - Fierce Pharma","headline":"J&J joins Argenx, UCB in the myasthenia gravis arena with FDA approval for FcRn blocker Imaavy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWV9QTlIxR0V4Z1hBbGlDUVZEWG5hb1NYRzFwWmVlZlA1S0lMR0h0akFrVGlKZy1NWnozc3gtdGg2Vm44TDNTejlKdWVOLVY2OWlEdkZEZmUtVmVBRk9mSkhwY1BVYlZMcVAycmdIUS1ldUVhSFN6M0NWWWw1LWhVSVpjbGltZHowWjQ5a0p5YjNscGllcDYtM0ViTk1tZmZGYjJZdDFSaWJXN1Vrb0IxOHpvMU5nVHJOZ19rTlVQUVFQTFpDS1Fj?oc=5","date":"2024-07-23","type":"regulatory","source":"nyas.org","summary":"Equivalence of Complex Drug Products: Scientific and Regulatory Challenges - nyas.org","headline":"Equivalence of Complex Drug Products: Scientific and Regulatory Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOOTJDVUhnMmRpNEJWUXBzWEhPRTBrdmdfbUlET1M0SnBsMEVOdXlYdTVxekxSeHBfV3E5dXJ0Tmw5MFhmTlphaG1VZmZGc2VpQi1FSENQVjkzeEt3bTlWd2t0NVBxQnpObmdyVUQweXl6TVlVdlRyWlRrWjFDcE8ySktSbDYtRFdxOEFJRmJ2Wk4ybE0?oc=5","date":"2023-02-06","type":"trial","source":"BioPharma Dive","summary":"J&J says drug it acquired from Momenta succeeds in study of ultra-rare condition - BioPharma Dive","headline":"J&J says drug it acquired from Momenta succeeds in study of ultra-rare condition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxQT3VBS0RzZjJVX0lQa1dnZUY2cl94Q3Q1SVliaHp6aDNSNmtLQWp1TGNWTmJfN3h6S0pKR0F3QnB6UGJiVWN1ekpISlZrdkFha28tNXNGUkhNempEeXBHYmQwamF0bGJzeUVJU3VsSE9Na2RXU2tSOTFjQVhDRG9pZ2FhU0lyazVFN3ZObnFkMF9FTXBEMTN0RzVuMUExbXhtdDBzVkpFYmd1dHBOejhMdzVBSHRxdmxONlN6Rk44X0VQTDg?oc=5","date":"2020-10-01","type":"pipeline","source":"PR Newswire","summary":"Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc. - PR Newswire","headline":"Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQV3dlT2pKYldDaEZ5dDItcS10ZjF2dU5xNWt0YkJZY25UU0MzdldqV3VhZ1FWOXVwM2E4NkNZQVg2X2dXdnVkSy1FaG5WdFNCRUhROWNKZ29FRG1tQ21rQnhyLUZtYVhPd0pQR0NrTERLYzh2LVYzdTd5dUg4Q3dkdy0xQnJDb2VSRzdpcGY5LS1aV3V5SFBhcDB0eXhoQjFyWFpDdl9iWVd2ZFMy?oc=5","date":"2020-08-19","type":"deal","source":"WSJ","summary":"Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion - WSJ","headline":"Johnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 Billion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQMEs0TDFIWUVVN3BDVVR6bFdDY0I2bWp4RVlGeVc5ZUZ0aGVfQVVpeURFLUdObEltbzh0OW45UWdxUC1YbFcwR1duNGIwZlAtckVtZHMwQzhpQmVaQ2thZFFxcG9nRlNqRjNCb2llc25NTnFmaDJqMElCcWJvT2FUcHpvSGlpejlheWdxRUZld1lxNkZ6MmFQVFZiRHY3UzdZblJadXBYb3FUWF9DWXJaeVdYNTMyYlFQcFltX1U1U0QyT3k2WUww?oc=5","date":"2020-08-19","type":"pipeline","source":"globenewswire.com","summary":"Momenta Enters Definitive Agreement with Johnson & Johnson - globenewswire.com","headline":"Momenta Enters Definitive Agreement with Johnson & Johnson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSkRpZk02dW5TQVpuN1hyQ3M3MUhHblVNSm5KQnhvM1dJS3M5bldJM2RHRkZrbE9ZRU1abElTSWtyWWVBTl9vOUpJaGtkNzcxdkYzWGtla1NNNmZOQWxLWXVkenh6MUhCWkdQUnhvTVZsdk9MYWowUmhYdGI2RkJhM2UxQmZ1S3NaakpVSEVWWDNwaC0xVGJkYtIBngFBVV95cUxQSC1INEF3NE5QZjBJQkNMM0JPN2IyekZmQUI0bDlVZUFBVUFLU2JFQktPY1VRMkU1NjdsXy1pb05Yekh4MFJZbHFZeXMtdTU1cTUzUVZZNzFNV1BDbjdHRkFDcWNpZER0TnlGVHR5a1NvM252QTV0djY2MlJXMTdSMEtJTlBDX1hUWS1uN2ZOeVZrV1Z2VUdhRkVoaE0yZw?oc=5","date":"2020-08-19","type":"deal","source":"CNBC","summary":"J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta - CNBC","headline":"J&J strikes $6.5 billion deal for autoimmune disease specialist Momenta","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxPRFRvZ0Mwdm16TjlrQ1FCUUZ6ZGxHdnhiOWRDbHA5ZUtVN2Jrc21lWDU4U25BdnU5cXFqTTkzT1VYVm9rVWJ6dVFXQm1zZ2IxbGFyckdYUDBQZHdHZUFsREVoT3c5bmY0X0NVMGloQ0djcndoa1VLYW5jam5lMGxoTFVYUmlPN1JJWEVPbWxBQTlVSW4yZ3BCTTNXd185NlhwZEdUUDVicG4xb09NbkRLeW02R19ScTdHOTkyMXJEcFoySy01bmllb2FQenlaU3BjdTNFcF9kNXVFcWZWUGJjdHRRVDhiZGYtRHA2dVhPUlFBSUNKLUtIZDFlN09GNEkzTW1kNGpzcnlvTUxJTEdUbm80aw?oc=5","date":"2020-08-19","type":"deal","source":"PR Newswire","summary":"Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases - PR Newswire","headline":"Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOZ3p6eW5adWV6dUJfY3NzRmRUMnA1ZTNzR3N1Ukd1ZVZjeFJ6cUFNdVdqNXJLN2h5Yk4xQndlWXAtb3h6bnpHbnVtaHR6T200U0JUVkJyWldDb2h1Y3hEbnRha1g0ODZPVndxQWtTN3d5TmF3MmE0ZFQ5eU40M2pzc3YzSDhvVGo0ZTh3NnJsTHJ6QkhpcjZ5V3BaX0ZvYW9oVzJtSTVIaE8xN010azdTOHVBNTRYWjZ4eDZCbg?oc=5","date":"2017-06-05","type":"pipeline","source":"The Boston Globe","summary":"Flex Pharma chief executive steps down - The Boston Globe","headline":"Flex Pharma chief executive steps down","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSjJzR0JJZ21CdXQyZ1NVNVRUX2h4SC05NGp1VWR5SkdxTktpMEJjUkpVdVJnVmMtcVVpd2pjNENfVUhZS3hrQXRjb093WjU3N2ZWNEZWaFRqc1VaeUt0bjdoODRkUzRRM3F6R2EzZjk2Z2lRTXFfejRzNTktZm9Wa3JuRnJlMXk2?oc=5","date":"2015-11-20","type":"pipeline","source":"JD Supra","summary":"Momenta Pharma., Inc. v. Teva Pharma. USA Inc. - JD Supra","headline":"Momenta Pharma., Inc. v. Teva Pharma. USA Inc.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOWUZKM1RPQTJRX0VOazJOX2d2NV9rX2VJWnMzUEN4MklMSG5Pem5vT2hqbzJSX1BHendlMWNhMUpLQTNiTVNDZXViQmMtVmhEZmwwQl9TS2c2c3AtQ0Z3Y25jM2JNWWdQZVRBOEQxV3FqbmZkb0ZOb0hsMWg5TTY0Ymc1dU5hdGNaVGNjOHZYRjVYNDExaWs4d1pxbC0zeXJWZDRzeg?oc=5","date":"2013-11-13","type":"pipeline","source":"Reuters","summary":"Natco Pharma surges on favourable U.S. court ruling - Reuters","headline":"Natco Pharma surges on favourable U.S. court ruling","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}